Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Testis expressed transcript, Y-linked 10 (TTTY10) is a long non-coding RNA gene located on the human Y chromosome, specifically restricted to males[1][3][5]. Like other lncRNAs, TTTY10 does not code for a protein but is transcribed as RNA. Bioinformatics and expression studies indicate that TTTY10 is co-expressed with genes involved in signal transduction, transcription regulation, cell adhesion, and differentiation, suggesting potential roles in gene regulatory networks, possibly impacting development or disease, particularly in male-specific tissues and contexts[4]. There is preliminary evidence associating TTTY10 with colorectal cancer progression based on co-expression with differentially expressed genes, implying it could serve as a molecular marker or have a regulatory role in tumor biology, but its precise biological function and clinical implications remain largely unknown[4][6][8][10]. No approved drugs or therapeutic interventions currently target TTTY10.
Not applicable (no drugs target TTTY10 directly)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Testis expressed transcript, Y-linked 10 (TTTY10).